Trades on 1 secondary market

Xilis

Xilis is a life-sciences / precision-oncology company developing patient-derived MicroOrganoSphere (MOS) technology to model a patient's tumor outside the body for functional drug testing and drug discovery. Surfaced as a portfolio company of GV and added to the API Evangelist network. Enrichment pr

minimal 7.7 / 100 0 APIs View provider profile →
CompanyLife SciencesPrecision OncologyBiotechnologyDrug DiscoveryOrganoids

Xilis is an API provider whose private shares are listed on 1 secondary market: EquityZen.

Where It Trades

EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.